1. Eribulin delays metastasis BUT not for too long, why?Download

2. Lymph node status is not a good marker for metastasis probability; why?

3. How do tumour cells survive in the blood?

4. Moving and growing cells exhibit different properties; how?

5. Companion Diagnostics: metastasis prediction in primary tumour patients

6. Case study in drug repurposing, with clinical validation

7. Identifying critical steps and novel targets.